Welcome to Endsleigh Place

After being bruised by last year's FY report, investors may have something to smile about when it comes to Smith & Nephew's progress

Touted as one of 2025's 'Magnificent Seven', Palantir is well in the throws of a correction. Is it still anywhere close to fair value?

Snake Oil salespeople are an understated threat to your wallet; it takes money to make money, but that does not mean giving your money away.

Investing? Start with these top resources that can guide your decision making.

When ETFs are mentioned, discussions essentially revolve around those tracking the S&P 500, the MSCI World index, the NASDAQ, or a...

Increased demand for private healthcare in the UK is here to stay, and Spire is a clear way to get exposure to it.